Related Experiment Videos
[Cellular immunity and epidemiologic analysis of pediatric patients with Mycoplasma pneumonia]
Objective:
To understand the of immuno-reactions of pediatrics patients with Mycoplasma pneumonia.
Methods:
90 patients suffered from M. pneumonia were administered and divided into three groups: mild group, severe group, and normal control group. T cell subset parameters, natural killer cell and the serumsoluble interleukin-2 recepter of all of above were determined.
Results:
Data showed:CD4 decreased at both acute and recovery stage of M. pneumonia, while CD8 remarkably increased (t = 2.63, 66, 2.77, 3.36, P < 0.05). SIL-2R level of all patients also greatly increased (t = 5.26, 3.19, P < 0.01), especially in the serious group.
Conclusion:
There are disturbances of cell-immune in M. pneumonia. The level of SIL-2R can serve as monitor on the degree of severeness of M. pneumonia. The incidence M. pneumonia appeared highest in the 10-14 year-old group.
Insights
Pediatric Mycoplasma pneumonia disrupts cell-immunity, with decreased CD4 and increased CD8 T-cells. Soluble interleukin-2 receptor (SIL-2R) levels indicate disease severity, peaking in the 10-14 age group.
Area of Science:
- Pediatric immunology
- Infectious disease research
- Respiratory medicine
Context:
- Mycoplasma pneumoniae is a common respiratory pathogen in children.
- Understanding the immune response is crucial for managing pediatric infections.
- Immune dysregulation plays a significant role in disease severity.
Purpose:
- To investigate the immuno-reactions in pediatric patients with Mycoplasma pneumonia.
- To analyze T cell subsets and serum soluble interleukin-2 receptor (SIL-2R) levels.
- To correlate immune parameters with disease severity and age group.
Summary:
- This study analyzed 90 pediatric patients with Mycoplasma pneumoniae, divided into mild, severe, and control groups.
- Results indicated decreased CD4+ T cells and increased CD8+ T cells during acute and recovery stages.
- Elevated SIL-2R levels were observed in all patients, particularly in the severe group, suggesting immune system activation.
Impact:
- The findings reveal significant disturbances in cell-mediated immunity during Mycoplasma pneumonia infections.
- Serum SIL-2R levels can serve as a valuable biomarker for monitoring disease severity.
- The highest incidence in the 10-14 year-old group highlights a key demographic for Mycoplasma pneumonia surveillance.